NCT00630227View on ClinicalTrials.gov

Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study

PHASE2CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Homogeneous Emphysema
Interventions
BIOLOGICAL

Biologic Lung Volume Reduction

20 mL Hydrogel

Trial Locations (8)

19140

Temple University Lung Center, Philadelphia

21204

St Josephs Medical Center, Towson

35249

University of Alabama, Birmingham

44195

Cleveland Clinic Foundation, Pulmonary Allergy & Critical Care Medicine, Cleveland

44302

Akron Medical Center, Akron

52242

University of Iowa Hospitals & Clinics, Iowa City

66606

Veritas Clinical Specialties, Topeka

85006

Pulmonary Associates, Phoenix

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00630227 - Biologic Lung Volume Reduction (BLVR) Phase 2 Homogeneous Study | Biotech Hunter | Biotech Hunter